131 – 140 of 148
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
(
- Contribution to journal › Article
- 2015
-
Mark
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
(
- Contribution to journal › Article
- 2014
-
Mark
Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.
(
- Contribution to journal › Article
-
Mark
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease.
(
- Contribution to journal › Article
-
Mark
A Quick Test of Cognitive Speed: norm-referenced criteria for 121 Italian adults aged 45 to 90 years.
(
- Contribution to journal › Article
- 2013
-
Mark
Dysphagia in Lewy body dementia - a clinical observational study of swallowing function by videofluoroscopic examination
(
- Contribution to journal › Article
-
Mark
Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
ROI-based analysis of diffusional kurtosis estimates for identification of MCI-patients at high risk for conversion to Alzheimer’s disease in a heterogeneous MCI cohort
2013) ISMRM, 2013(
- Contribution to conference › Poster
- 2012
-
Mark
Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia.
(
- Contribution to journal › Article